Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis

Journal of Ethnopharmacology

Volumn 150, Issue 3, 2013, Pages 925-934

  Marín, Marta ^a   María Giner, Rosa ^a   Ríos, José Luis ^a   Carmen Recio, María ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Acute ulcerative colitis; Balb C; Chronic colitis; Dextran sulfate sodium; Ellagic acid

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXTRAN SULFATE; ELLAGIC ACID; GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; TRANSCRIPTION INITIATION; ULCERATIVE COLITIS; WESTERN BLOTTING;

LYTHRACEAE; MUS; PUNICA GRANATUM;

ACUTE ULCERATIVE COLITIS; BALB/C; CHRONIC COLITIS; DEXTRAN SULFATE SODIUM; ELLAGIC ACID;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; ELLAGIC ACID; FEMALE; I-KAPPA B PROTEINS; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; STAT3 TRANSCRIPTION FACTOR;

EID: 84889100502     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.09.030     Document Type: Article

References (64)

1. I. Andújar, J.L. Ríos, R.M. Giner, J.M. Cerdá, and M.C. Recio Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in Balb/C mice Evidence-Based Complement. Altern. Med. 2012 15 10.1155/2012/271606 (Article ID 271606)
2. V. Arulampalam, and S. Pettersson Uncoupling the p38 MAPK kinase in IBD: a double edged sword? Gut 50 2002 446 447 (Pubitemid 34638857)
3. R. Atreya, I. Atreya, and M.F. Neurath Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease Ann. N.Y. Acad. Sci. 1072 2006 98 113 (Pubitemid 44448446)
4. I. Atreya, R. Atreya, and M.F. Neurath NF-κB in inflammatory bowel disease J. Intern. Med. 263 2008 591 596
5. R. Atreya, J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, D. Strand, J. Czaja, J.F. Schlaak, H.A. Lehr, F. Autschbach, G. Schurmann, N. Nishimoto, K. Yoshizaki, H. Ito, T. Kishimoto, P.R. Galle, S. Rose-John, and M.F. Neurath Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo Nat. Med. 6 2000 583 588 (Pubitemid 30305911)
6. I. Bala, V. Bhardwaj, S. Hariharan, and M.N. Kumar Analytical methods for assay of ellagic acid and its solubility studies J. Pharm. Biomed. Anal. 40 2006 206 210 (Pubitemid 43065248)
7. C. Becker, M.C. Fantini, C. Schramm, H.A. Lehr, S. Wirtz, A. Nikolaev, J. Burg, S. Strand, R. Kiesslich, S. Huber, H. Ito, N. Nishimoto, K. Yoshizaki, T. Kishimoto, P.R. Galle, M. Blessing, S. Rose-John, and M.F. Neurath TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 2004 491 501 (Pubitemid 39370505)
8. C. Bell, and S. Hawthorne Ellagic acid, pomegranate and prostate cancer - a mini review J. Pharm. Pharmacol. 60 2008 139 144 (Pubitemid 351211828)
9. A. Berni, M.R. Grossi, G. Pepe, S. Filippi, S. Muthukumar, C. Papeschi, A.T. Natarajan, and F. Palitti Protective effect of ellagic acid (EA) on micronucleus formation induced by N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) in mammalian cells, in in vitro assays and in vivo Mutat. Res. 746 2012 60 65
10. A.M. Beserra, P.I. Calegari, C. Souza Mdo, R.A. Dos Santos, J.C. Lima, R.M. Silva, S.O. Balogun, and D.T. Martins Gastroprotective and ulcer-healing mechanisms of ellagic acid in experimental rats J. Agric. Food Chem. 59 2011 6957 6965
11. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
12. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J. Invest. Dermatol. 78 1982 206 209 (Pubitemid 12171880)
13. K.J. Campbell, and N.D. Perkins Regulation of NF-κB function Biochem. Soc. Symp. 2006 165 180
14. P.C. Chao, C.C. Hsu, and M.C. Yin Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice Nutr. Metab. 6 2009 33
15. C.Y. Chao, M.C. Mong, K.C Chan, and M.C. Yin Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice Mol. Nutr. Food Res. 54 2010 388 395
16. M.L. Clapper, H.S. Cooper, and W.C. Chang Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions Acta Pharmacol. Sin. 28 2007 1450 1459 (Pubitemid 47366692)
17. H.S. Cooper, S.N. Murthy, R.S. Shah, and D.J. Sedergran Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab. Invest. 69 1993 238 249
18. S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside Gut 61 2012 918 932
19. N. Devipriya, A.R. Sudheer, M. Srinivasan, and V.P. Menon Effect of ellagic acid, a plant polyphenol, on fibrotic markers (MMPs and TIMPs) during alcohol-induced hepatotoxicity Toxicol. Mech. Methods 17 2007 349 356 (Pubitemid 47124023)
20. A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Oresland, A. Windsor, E.F. Stange, S.P. Travis European Crohn's and Colitis Organisation (ECCO) The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management J. Crohn's Colitis 4 2010 28 62
21. M. Falsaperla, G. Morgia, A. Tartarone, R. Ardito, and G. Romano Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate Eur. Urol. 47 2005 449 454 (discussion 454-455) (Pubitemid 40357886)
22. Y.J. Feng, and Y.Y. Li The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease J. Dig. Dis. 12 2011 327 332
23. M.I. Gil, F.A. Tomàs-Barberàn, B. Hess-Pierce, D.M. Holcroft, and A.A. Kader Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing J. Agricult. Food Chem. 48 2000 4581 4589
24. E. Giner, I. Andújar, M.C. Recio, J.L. Ríos, J.M. Cerdá-Nicolás, and R.M. Giner Oleuropein ameliorates acute colitis in mice J. Agricult. Food Chem. 59 2011 12882 12892
25. H.P. Glauert, K. Calfee-Mason, D.N. Stemm, J.C Tharappel, and B.T. Spear Dietary antioxidants in the prevention of hepatocarcinogenesis: a review Mol. Nutr. Food Res. 54 2010 875 896
26. A. González-Sarráas, J.A. Giménez-Bastida, M.T. García-Conesa, M.B. Gómez-Sánchez, N.V. García-Talavera, A. Gil-Izquierdo, C. Sánchez-Alvarez, L.O. Fontana-Compiano, J.P. Morga-Egea, F.A. Pastor-Quirante, F. Martínez- Díaz, F.A. Tomás-Barberán, and J.C. Espín Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice Mol. Nutr. Food Res. 54 2010 311 322
27. E. Hollenbach, M. Neumann, M. Vieth, A. Roessner, P. Malfertheiner, and M. Naumann Inhibition of p38 MAP kinase- and RICK/NF-κB-signaling suppresses inflammatory bowel disease FASEB J. 18 2004 1550 1552 (Pubitemid 39561629)
28. P.R. Holt, S. Katz, and R. Kirshoff Curcumin therapy in inflammatory bowel disease: a pilot study Dig. Dis. Sci. 50 2005 2191 2193 (Pubitemid 41504112)
29. T. Karrasch, and C. Jobin NF-κB and the intestine: friend or foe? Inflammatory Bowel Dis. 14 2008 114 124
30. M.Y. Kuo, H.C. Ou, W.J. Lee, W.W. Kuo, L.L. Hwang, T.Y. Song, C.Y. Huang, T.H. Chiu, K.L. Tsai, C.S. Tsai, and W.H. Sheu Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells J. Agric. Food Chem. 59 2011 5100 5108
31. F. Lei, D.M. Xing, L. Xiang, Y.N. Zhao, W. Wang, L.J. Zhang, and L.D. Du Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract J. Chromatogr. B 796 2003 189 194 (Pubitemid 38352723)
32. J.D. Lewis, J.J. Deren, and G.R. Lichtenstein Cancer risk in patients with inflammatory bowel disease Gastroenterol. Clin. North Am. 28 1999 459 477 (x) (Pubitemid 29306488)
33. R. Longtin The pomegranate: Nature's power fruit? J. Nat. Cancer Inst. 95 2003 346 348 (Pubitemid 36395250)
34. M. Mähler, I.J. Bristol, E.H. Leiter, A.E. Workman, E.H. Birkenmeier, C.O. Elson, and J.P. Sundberg Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis Am. J. Physiol. 274 1998 G544 G551
35. P.S. Makena, and K.T. Chung Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity Food. Chem. Toxicol. 45 2007 1899 1909 (Pubitemid 47238204)
36. A. Mantovani Molecular pathways linking inflammation and cancer Curr. Mol. Med. 10 2010 369 373
37. J. Meier, and A. Sturm Current treatment of ulcerative colitis World J. Gastroenterol. 17 2011 3204 3212
38. S. Melgar, A. Karlsson, and E. Michaelsson Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am. J. Physiol. Gastrointest. Liver Physiol. 288 2005 G1328 G1338
39. E.A. Miles, P. Zoubouli, and P.C. Calder Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures Nutrition 21 2005 389 394 (Pubitemid 40387940)
40. A. Mizoguchi, and E. Mizoguchi Inflammatory bowel disease, past, present and future: lessons from animal models J. Gastroenterol. 43 2008 1 17 (Pubitemid 351324980)
41. D.C. Montrose, N.A. Horelik, J.P. Madigan, G.D. Stoner, L.S. Wang, R.S. Bruno, H.J. Park, C. Giardina, and D.W. Rosenberg Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis Carcinogenesis 32 2011 343 350
42. N.H. Nam Naturally occurring NF-κB inhibitors Mini-Rev. Med. Chem. 6 2006 945 951
43. Y. Ogawa, K. Kanatsu, T. Iino, S. Kato, Y.I. Jeong, N. Shibata, K. Takada, and K. Takeuchi Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats Life Sci. 71 2002 827 839 (Pubitemid 34628824)
44. E. Päivärinta, A.M. Pajari, R. Törrönen, and M. Mutanen Ellagic acid and natural sources of ellagitannins as possible chemopreventive agents against intestinal tumorigenesis in the Min mouse Nutr. Cancer 54 2006 79 83 (Pubitemid 44141338)
45. S.H. Park, J.L. Kim, E.S. Lee, S.Y. Han, J.H. Gong, M.K. Kang, and Y.H. Kang Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages J. Nutr. 141 2011 1931 1937
46. C. Pohl, A. Hombach, and W. Kruis Chronic inflammatory bowel disease and cancer Hepatogastroenterology 47 2000 57 70 (Pubitemid 30085390)
47. K.I. Priyadarsini, S.M. Khopde, S.S. Kumar, and H. Mohan Free radical studies of ellagic acid, a natural phenolic antioxidant J. Agricult. Food Chem. 50 2002 2200 2206 (Pubitemid 34260032)
48. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J. 22 2008 659 661 (Pubitemid 351348146)
49. P. Riso, D. Klimis-Zacas, C. Del Bo', D. Martini, J. Campolo, S. Vendrame, P. Møller, S. Loft, R. De Maria, and M. Porrini Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors Eur. J. Nutr. 52 2013 949 961
50. G. Rogler, K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P.A. Baeuerle, J. Schölmerich, and V. Gross Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 1998 357 369 (Pubitemid 28363428)
51. S. Rosengren, G.S. Firestein, and D.L. Boyle Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay Clin. Diagn. Lab. Immunol. 10 2003 1002 1010 (Pubitemid 37444265)
52. M.A. Rosillo, M. Sánchez-Hidalgo, A. Cardeno, and C. Alarcón de la Lastra Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease Biochem. Pharmacol. 82 2011 737 745
53. M.A. Rosillo, M. Sanchez-Hidalgo, A. Cardeno, M. Aparicio-Soto, S. Sánchez-Fidalgo, I. Villegas, and C.A. de la Lastra Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colon inflammation in rats Pharmacol. Res. 66 2012 235 242
54. F. Sánchez de Medina, A. Daddaoua, P. Requena, F. Capitán-Cañadas, A. Zarzuelo, M.D. Suárez, and O. Martínez-Augustin New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation Proc. Nutr. Soc. 69 2010 454 462
55. H. Sann, J. von Erichsen, M. Hessmann, A. Pahl, and A. Hoffmeyer Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice Life Sci. 92 2013 708 718
56. K. Singh, A.S. Jaggi, and N. Singh Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice Phytother. Res. 23 2009 1565 1574
57. P.N. Soh, B. Witkowski, D. Olagnier, M.L. Nicolau, M.C. García-Alvarez, A. Berry, and F. Benoit-Vical In vitro and in vivo properties of ellagic acid in malaria treatment Antimicrob. Agents Chemother. 53 2009 1100 1106
58. E. Talero, J. Ávila-Roman, and V. Motilva Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer Curr. Pharm. Des. 18 2012 3939 3965
59. S. Umesalma, and G. Sudhandiran Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-κB, iNOS, COX-2, TNF-α, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis Basic Clin. Pharmacol. Toxicol. 107 2010 650 655
60. A. Van Beelen Granlund, A.E. Ostvik, O. Brenna, S.H. Torp, B.I. Gustafsson, and A.K. Sandvik REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation Cell Tissue Res. 2013 10.1007/s00441-013-1592-z
61. C.E. Vitor, C.P. Figueiredo, D.B. Hara, A.F. Bento, T.L. Mazzuco, and J.B. Calixto Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, α- and β-amyrin, in a mouse model of colitis Br. J. Pharmacol. 157 2009 1034 1044
62. J. Youn, J.S. Lee, H.K. Na, J.K. Kundu, and Y.J. Surh Resveratrol and piceatannol inhibit iNOS expression and NF-κB activation in dextran sulfate sodium-induced mouse colitis Nutr. Cancer 61 2009 847 854
63. R. Zamora-Ros, V. Knaze, L. Luján-Barroso, N. Slimani, I. Romieu, V. Fedirko, and M.S. de Magistris Estimated dietary intakes of flavonols, flavanones and flavones in the European prospective investigation into cancer and nutrition (EPIC) 24 h dietary recall cohort Br. J. Nutr. 106 2011 1915 1925
64. H. Zhou, C.S. Beevers, and S. Huang The targets of curcumin Curr. Drug Targets 12 2011 332 347